id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-0101-1319,FDA,FDA-2015-N-0101,Advice Letter from FDA CDER to American Chemistry Council,Other,Letter(s),2016-12-30T05:00:00Z,2016,12,2016-12-30T05:00:00Z,,2016-12-30T18:11:04Z,,0,0,0900006482442595
FDA-2015-N-0101-1318,FDA,FDA-2015-N-0101,Request for a Type C Meeting from American Chemistry Council,Other,Request,2016-10-25T04:00:00Z,2016,10,2016-10-25T04:00:00Z,,2016-10-25T20:07:00Z,,0,0,09000064823379ab
FDA-2015-N-0101-1315,FDA,FDA-2015-N-0101,Response Letter from FDA CDER to American Cleaning Institute,Supporting & Related Material,Background Material,2016-09-29T04:00:00Z,2016,9,,,2016-09-29T15:41:50Z,,0,0,0900006482280335
FDA-2015-N-0101-1313,FDA,FDA-2015-N-0101,Attachment 3: GOJO Appendix B ICPIC Poster Presentation re: Comment from Beth Glasgow,Supporting & Related Material,Background Material,2016-09-19T04:00:00Z,2016,9,,,2016-09-19T12:26:47Z,,0,0,09000064822263cc
FDA-2015-N-0101-1311,FDA,FDA-2015-N-0101,Attachment 1 : GOJO Cover Letter Approach and Plan to Address Key Elements for maximal Use PK Trial (MUsT) Design re: Comment from Beth Glasgow,Supporting & Related Material,Background Material,2016-09-19T04:00:00Z,2016,9,,,2016-09-19T12:24:10Z,,0,0,090000648221d398
FDA-2015-N-0101-1312,FDA,FDA-2015-N-0101,Attachment 2: GOJO Appendix A Dr. Boyce Maximal Use Report re: Comment from Beth Glasgow,Supporting & Related Material,Background Material,2016-09-19T04:00:00Z,2016,9,,,2016-09-19T12:23:59Z,,0,0,09000064822263cb
FDA-2015-N-0101-1314,FDA,FDA-2015-N-0101,Supplement (Work Plan) from American Cleaning Institute,Supporting & Related Material,Background Material,2016-09-19T04:00:00Z,2016,9,,,2016-09-19T12:47:54Z,,0,0,09000064822263d0
FDA-2015-N-0101-1309,FDA,FDA-2015-N-0101,Metting Request - Written Response from FDA CDER to American Chemistry Council,Other,Letter(s),2016-08-22T04:00:00Z,2016,8,2016-08-22T04:00:00Z,,2016-12-15T14:42:28Z,,0,0,090000648218d4a2
FDA-2015-N-0101-1305,FDA,FDA-2015-N-0101,Request for a Type C Meeting from American Chemistry Council Isopropanol Panel,Other,Request,2016-08-12T04:00:00Z,2016,8,2016-08-12T04:00:00Z,,2016-08-12T16:38:08Z,,0,0,0900006482035f88
FDA-2015-N-0101-1306,FDA,FDA-2015-N-0101,Response from American Cleaning Institute to FDA CDER,Other,Response(s),2016-08-12T04:00:00Z,2016,8,2016-08-12T04:00:00Z,,2016-08-12T16:54:05Z,,0,0,0900006482060fe5
FDA-2015-N-0101-1308,FDA,FDA-2015-N-0101,Handwashing Habits Child Care Workers GLM 16123 National Online Study with Child Care Providers Conducted on Behalf of the American Cleaning Institute (April 2016) from Lewis and Harrison (Lonza Inc.),Supporting & Related Material,Background Material,2016-08-12T04:00:00Z,2016,8,,,2016-08-12T19:21:02Z,,0,0,0900006482172254
FDA-2015-N-0101-1307,FDA,FDA-2015-N-0101,Advice Letter from FDA CDER to American Cleaning Institute,Other,Letter(s),2016-08-12T04:00:00Z,2016,8,2016-08-12T04:00:00Z,,2016-08-12T18:36:40Z,,0,0,0900006482171e29
FDA-2015-N-0101-1303,FDA,FDA-2015-N-0101,"Letter from FDA CDER to American Cleaning Institute Responding to Additional Questions from February 19, 2015 Meeting",Other,Letter(s),2016-07-21T04:00:00Z,2016,7,2016-07-21T04:00:00Z,,2016-07-21T13:40:13Z,,0,0,09000064820ddd9d
FDA-2015-N-0101-1302,FDA,FDA-2015-N-0101,Advice letter to American Cleaning Institute - 3-8-2016,Supporting & Related Material,Background Material,2016-07-19T04:00:00Z,2016,7,,,2016-07-19T21:07:34Z,,0,0,09000064820cf316
FDA-2015-N-0101-1298,FDA,FDA-2015-N-0101,Study No .3: Developmental Toxicity Evaluation of Alkyl Dimethyl Benzyl Ammonium Chloride (ADBAC) Administered by Gavage to CD Rats re: Studies from ADBAC Issues Steering Committee (Lewis and Harrison),Supporting & Related Material,Studies and Reports,2016-05-26T04:00:00Z,2016,5,,,2018-02-07T16:54:59Z,,0,0,0900006481ff0a53
FDA-2015-N-0101-1301,FDA,FDA-2015-N-0101,Study No. 9: Chronic Dietary Toxicity/Oncogenicity Study with Alkyl Dimethyl Benzyl Ammonium Chloride (ADBAC) in Mice re: Studies from ADBAC Issues Steering Committee (Lewis and Harrison),Supporting & Related Material,Studies and Reports,2016-05-26T04:00:00Z,2016,5,,,2018-02-07T16:54:32Z,,0,0,0900006481ff0a5c
FDA-2015-N-0101-1299,FDA,FDA-2015-N-0101,Study No. 5: Evaluation of ADBAC in One-Year Chronic Dietary Toxicity Study in Dogs re: Studies from ADBAC Issues Steering Committee (Lewis and Harrison),Supporting & Related Material,Studies and Reports,2016-05-26T04:00:00Z,2016,5,,,2018-02-07T16:55:12Z,,0,0,0900006481ff0a55
FDA-2015-N-0101-1297,FDA,FDA-2015-N-0101,Study No.1: Developmental Toxicity Evaluation of Alkyl Dimethyl Benzyl Ammonium Chloride (ADBAC) Administered by Gavage to New Zealand White Rabbits re: Studies from ADBAC Issues Steering Committee (Lewis and Harrison),Supporting & Related Material,Studies and Reports,2016-05-26T04:00:00Z,2016,5,,,2018-02-07T16:54:43Z,,0,0,0900006481ff07bb
FDA-2015-N-0101-1300,FDA,FDA-2015-N-0101,Study No. 8: Chronic Dietary Toxicity/Oncogenicity Study with Alkyl Dimethyl Benzyl Ammonium Chloride (ADBAC) in Rats re: Studies from ADBAC Issues Steering Committee (Lewis and Harrison),Supporting & Related Material,Studies and Reports,2016-05-26T04:00:00Z,2016,5,,,2018-02-07T16:54:21Z,,0,0,0900006481ff0a5b
FDA-2015-N-0101-1296,FDA,FDA-2015-N-0101,Studies from ADBAC Issues Steering Committee (Lewis and Harrison),Other,Studies,2016-05-25T04:00:00Z,2016,5,,,2018-02-07T16:50:16Z,,0,0,0900006481ff072d
FDA-2015-N-0101-1294,FDA,FDA-2015-N-0101,"Attachment 13 Schade and Roukis Use of a Surgical Preparation and Sterile Dressing Change During Office Visit Treatment of Chronic Foot and Ankle
Wounds Decreases the Incidence of Infection and Treatment Costs re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-03-28T04:00:00Z,2016,3,,,2016-03-28T13:23:26Z,,0,0,0900006481ca5f3d
FDA-2015-N-0101-1293,FDA,FDA-2015-N-0101,Meeting Minutes between FDA and the American Chemistry Council,Other,Minutes,2016-02-26T05:00:00Z,2016,2,2016-02-26T05:00:00Z,,2016-02-26T15:30:27Z,,0,0,0900006481e8a9ce
FDA-2015-N-0101-1285,FDA,FDA-2015-N-0101,"Attachment 5 Time Kill Study Report Conducted by NIPA Lab Inc re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T19:58:35Z,,0,0,0900006481ca3056
FDA-2015-N-0101-1287,FDA,FDA-2015-N-0101,"Attachment 7 Cited Article from University of Minnesota re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T20:11:40Z,,0,0,0900006481ca3058
FDA-2015-N-0101-1291,FDA,FDA-2015-N-0101,"Attachment 11 Abstract from University of Minnesota re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T20:16:15Z,,0,0,0900006481ca305c
FDA-2015-N-0101-1281,FDA,FDA-2015-N-0101,"Table of Contents re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T19:51:41Z,,0,0,0900006481ca2f98
FDA-2015-N-0101-1282,FDA,FDA-2015-N-0101,"Attachment 1 Hill Top Biolabs, Inc - Cup scrub method Suppression of Skin Microflora re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T19:52:42Z,,0,0,0900006481ca3052
FDA-2015-N-0101-1286,FDA,FDA-2015-N-0101,"Attachment 6 Antimicrobial Testing of Surgical Scrub Formulation Report Conducted by Ferro Corp re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T19:59:51Z,,0,0,0900006481ca3057
FDA-2015-N-0101-1289,FDA,FDA-2015-N-0101,"Attachment 9 Cited Article from University of Minnesota re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T20:14:00Z,,0,0,0900006481ca305a
FDA-2015-N-0101-1292,FDA,FDA-2015-N-0101,"Attachment 12 Catherine L. Statz Fighting Wound Infection re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T20:17:24Z,,0,0,0900006481ca305e
FDA-2015-N-0101-1288,FDA,FDA-2015-N-0101,"Attachment 8 Techni-Care vs Mycobacterium Bovis TMC re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T20:12:34Z,,0,0,0900006481ca3059
FDA-2015-N-0101-1283,FDA,FDA-2015-N-0101,"Attachment 3 Eyetex Screen - Occular Irritation re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T19:55:20Z,,0,0,0900006481ca3054
FDA-2015-N-0101-1290,FDA,FDA-2015-N-0101,"Attachment 10 Cited Article from University of Florida College of Veterinary Medicine re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T20:15:23Z,,0,0,0900006481ca305b
FDA-2015-N-0101-1284,FDA,FDA-2015-N-0101,"Attachment 4 Acute Oral Toxicity in Rats re: Comment from Care-Tech Laboratories, Inc",Supporting & Related Material,Background Material,2016-01-11T05:00:00Z,2016,1,,,2016-01-11T19:57:10Z,,0,0,0900006481ca3055